Endocrinology / diabetes clinical trials recruiting in New York

45 recruiting endocrinology / diabetes trials match in New York. Showing 20.

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerRecruiting

  Phase 3 · Hoffmann-La Roche · New York, New York

• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerRecruiting

  N/A · Natera, Inc. · Babylon, New York

• Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Recruiting

  Phase 3 · NRG Oncology · Bay Shore, New York

• Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaRecruiting

  Phase 3 · SWOG Cancer Research Network · La Jolla, California

• Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruiting

  Phase 1 · Nammi Therapeutics Inc · New York, New York

• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsRecruiting

  Phase 1 / Phase 2 · Artios Pharma Ltd · East Syracuse, New York

• A Study of MGC026 in Participants With Advanced Solid TumorsRecruiting

  Phase 1 · MacroGenics · Lake Success, New York

• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruiting

  Phase 3 · Eli Lilly and Company · New York, New York

• A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaRecruiting

  Phase 2 · Children's Oncology Group · Albany, New York

• Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaRecruiting

  Phase 2 · National Cancer Institute (NCI) · Rochester, New York

• Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruiting

  Phase 2 · National Cancer Institute (NCI) · Buffalo, New York

• NYSCF Scientific Discovery BiobankRecruiting

  N/A · New York Stem Cell Foundation Research Institute · New York, New York

• Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerRecruiting

  Phase 3 · NRG Oncology · Brooklyn, New York

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceRecruiting

  Phase 3 · Stemline Therapeutics, Inc. · Brooklyn, New York

• A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian CancerRecruiting

  N/A · NRG Oncology · Albany, New York

• AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightRecruiting

  Phase 3 · Novo Nordisk A/S · New York, New York

• A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid TumorsRecruiting

  Phase 1 / Phase 2 · Day One Biopharmaceuticals, Inc. · New York, New York

• Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesRecruiting

  Phase 4 · VA Office of Research and Development · New York, New York

• Maternal Smoking Cessation and Pediatric Obesity PreventionRecruiting

  N/A · State University of New York at Buffalo · Buffalo, New York

• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Recruiting

  Phase 3 · Eli Lilly and Company · Chandler, Arizona

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.